Product category:
Assay kits
News Release from: Molecular Devices | Subject: Assay kits
Edited by the Laboratorytalk Editorial
Team on 19 November 2002
Eight new assay kits
These new assay kits further extend the technology platform in high throughput screening while offering ease of miniaturisation and low cost-per-well
Molecular Devices has announced the launch of six new assay kits using its proprietary Imap technology and two new kits in the proprietary CatchPoint format The Imap kits - Prak, MSK1, Src, Fyn, Lck, and PP2A assay kits - all incorporate enzymes from Upstate Biotechnology
This article was originally published on Laboratorytalk on 4 Jul 2003 at 8.00am (UK)
Related stories
New assay kits exploit proprietary technology
These new assay kits further extend the technology platform in HTS with the same ease of miniaturisation and low cost-per-well
Assay kits extend technology further
New assay kits extend proprietary technology platform into such areas as inflammation, oncology and allergic diseases and include non-specific screening tool for tyrosine kinases
The CatchPoint cGMP assay kits are plate-based assays used to measure cGMP, an important cell signalling molecule.
Molecular Devices's Imap technology is rapidly becoming an established assay format for kinase activity because it does not use specific antibodies.
These new assay kits further extend the technology platform in HTS with the same ease of miniaturisation and low cost-per-well.
Molecular Devices now offers 11 specific Imap kits as well as an Imap purchase plan to provide components to companies assaying proprietary kinases.
The CatchPoint cGMP assay kit is the second product in a family which is preformatted in 384-well plates, the most popular format for drug discovery.
For the important research market, a CatchPoint cGMP assay kit is also formatted in 96-well plates.
"Phosphatases and kinases are screened at all major pharmaceutical companies and each additional kit in our Imap portfolio builds more utility onto this technology platform.
Our customers have six more reasons to adopt Imap," stated Stephen Oldfield, vice president of worldwide marketing at Molecular Devices.
"While Imap provides a fluorescence polarisation signal, CatchPoint modulates fluorescence intensity. Request a free brochure from Molecular Devices ...
These diverse fluorescent readout modes leverage Molecular Devices's significant installed base of Analyst and Gemini microplate readers, providing solutions for thousands of researchers at all stages in the drug development pipeline.".
• Molecular Devices: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
